venBio Partners
Latest statistics and disclosures from venBio Partners's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Rayzebio, ALXO, PHVS, HRMY, SLRN, and represent 99.71% of venBio Partners's stock portfolio.
- Added to shares of these 1 stock: PHVS (+$18M).
- Reduced shares in these 1 stock: VTYX (-$26M).
- Sold out of its position in VTYX.
- venBio Partners was a net seller of stock by $-8.0M.
- venBio Partners has $667M in assets under management (AUM), dropping by 89.19%.
- Central Index Key (CIK): 0001776382
Tip: Access up to 7 years of quarterly data
Positions held by venBio Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelPortfolio Holdings for venBio Partners
venBio Partners holds 7 positions in its portfolio as reported in the December 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Rayzebio | 48.1 | $321M | 5.2M | 62.17 |
|
|
Alx Oncology Hldgs (ALXO) | 21.6 | $144M | 9.7M | 14.89 |
|
|
Pharvaris N V (PHVS) | 20.7 | $138M | +15% | 4.9M | 28.05 |
|
Harmony Biosciences Hldgs In (HRMY) | 5.0 | $33M | 1.0M | 32.30 |
|
|
Acelyrin (SLRN) | 4.3 | $29M | 3.9M | 7.46 |
|
|
Elevation Oncology (ELEV) | 0.2 | $1.6M | 2.9M | 0.54 |
|
|
Impel Neuropharma (IMPLQ) | 0.1 | $341k | 2.8M | 0.12 |
|
Past Filings by venBio Partners
SEC 13F filings are viewable for venBio Partners going back to 2019
- venBio Partners 2023 Q4 filed Feb. 14, 2024
- venBio Partners 2023 Q3 filed Nov. 14, 2023
- venBio Partners 2023 Q2 filed Aug. 14, 2023
- venBio Partners 2023 Q1 filed May 15, 2023
- venBio Partners 2022 Q4 filed Feb. 14, 2023
- venBio Partners 2022 Q3 filed Nov. 14, 2022
- venBio Partners 2022 Q2 filed Aug. 15, 2022
- venBio Partners 2022 Q1 filed May 16, 2022
- venBio Partners 2021 Q4 filed Feb. 14, 2022
- venBio Partners 2021 Q3 filed Nov. 15, 2021
- venBio Partners 2021 Q2 filed Aug. 16, 2021
- venBio Partners 2021 Q1 filed May 17, 2021
- venBio Partners 2020 Q4 filed Feb. 16, 2021
- venBio Partners 2020 Q3 filed Nov. 16, 2020
- venBio Partners 2020 Q2 filed Aug. 14, 2020
- venBio Partners 2018 Q4 filed May 26, 2020